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The effect of long-chain polyunsaturated fatty acids intake
during pregnancy on adiposity of healthy full-term offspring
at birth
L Pereira-da-Silva1,2,3, C Cabo3, AC Moreira3, AL Papoila4,5, D Virella1,4, R Neves2, KM Bridges6,7 and G Cordeiro-Ferreira1,2
OBJECTIVE: The adjusted effect of long-chain polyunsaturated fatty acid (LCPUFA) intake during pregnancy on adiposity at birth of
healthy full-term appropriate-for-gestational age neonates was evaluated.
STUDY DESIGN: In a cross-sectional convenience sample of 100 mother and infant dyads, LCPUFA intake during pregnancy was
assessed by food frequency questionnaire with nutrient intake calculated using Food Processor Plus. Linear regression models for
neonatal body composition measurements, assessed by air displacement plethysmography and anthropometry, were adjusted for
maternal LCPUFA intakes, energy and macronutrient intakes, prepregnancy body mass index and gestational weight gain.
RESULT: Positive associations between maternal docosahexaenoic acid intake and ponderal index in male offspring (β= 0.165; 95%
conﬁdence interval (CI): 0.031–0.299; P= 0.017), and between n-6:n-3 LCPUFA ratio intake and fat mass (β= 0.021; 95% CI: 0.002–
0.041; P= 0.034) and percentage of fat mass (β= 0.636; 95% CI: 0.125–1.147; P= 0.016) in female offspring were found.
CONCLUSION: Using a reliable validated method to assess body composition, adjusted positive associations between maternal
docosahexaenoic acid intake and birth size in male offspring and between n-6:n-3 LCPUFA ratio intake and adiposity in female
offspring were found, suggesting that maternal LCPUFA intake strongly inﬂuences fetal body composition.
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INTRODUCTION
Insufﬁcient intrauterine supply of energy, macronutrients and/or
micronutrients, during a period of rapid growth, may result in
metabolic and body composition alterations.1 Both n-3 and n-6
long-chain polyunsaturated fatty acids (LCPUFA) are claimed as
indispensable for fetal growth and development, despite the
insufﬁcient scientiﬁc evidence on their individual effect on fetal
body composition.2 In particular, the fetus has limited ability to
synthesize docosahexaenoic acid (DHA), and supply is almost
entirely dependent upon maternal transfer.3
Randomized controlled trials evaluating the effect of maternal
LCPUFA intake on offspring health have mainly been focused on
maternal n-3 LCPUFA intake, and the offspring growth has been
assessed as a secondary outcome.1,2,4–6 Systematic reviews on
these trials have found associations between n-3 LCPUFA intake
and offspring birth size.2,4,5,7 These associations have been inter-
preted as a consequence of prolonged gestation by 2 to 2.5 days
rather than a direct effect on fetal growth, reﬂected by increase
in birth weight around 50 g;2,4,7 however, this effect disappears
when adjusted for gestational age.8 The effect of LCPUFA on fetal
growth has been usually analyzed without adjustment for main
cofactors with potential inﬂuence on fetal growth,6 including
prepregnancy body mass index (BMI), energy and macronutrient
intake, and gestational weight gain (GWG).9,10
Eicosanoids derived from arachidonic acid (n-6 family) appear to
have an adipogenic effect, by providing a molecular link between
fatty acid uptake and preadipocytes differentiation during early
hyperplasic growth stages of adipose tissue, whereas eicosanoids
derived from eicosapentaenoic acid and DHA (n-3 family) seem to
counteract this process.1,4,6,11 Data from many observational and
interventional studies in humans, even those measuring fatty
acids proﬁle in maternal blood, are insufﬁcient to support the
hypothesis that maternal n-3 LCPUFA diets exert an antiadipo-
genic action on the fetus, and are inconsistent with some ﬁndings
in animal studies.12 Most studies have relied on birth weight and
indirect growth variables such as BMI or BMI Z-scores, which do
not distinguish between the major components of body mass.6
Other studies13,14 have used skinfolds to estimate body fat mass,
but limitations of this method in predicting body fat in neonatal
age have been reported.15 Assessment of body composition,
rather than birth size alone, should give better insight into quality
of growth and contribute to clarify the lack of consistency
between studies on the effect of maternal LCPUFA intake on fetal
growth.16
To our knowledge, no reliable validated method has been used
to date to assess the effect of maternal LCPUFA intake on
adiposity of offspring at birth.1 Air displacement plethysmography
(ADP) is a reliable method validated in neonates17 to assess body
composition in a two-compartment model; ADP thus allows for an
accurate assessment of adiposity, deﬁned by the percentage of
body fat.18 This method is convenient for use in neonates since it
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is noninvasive, relatively rapid to perform and not affected by
movements.16
This study explores the effect of LCPUFA intake during
pregnancy on the adiposity at birth of healthy full-term
appropriate-for-gestational age neonates, assessed by ADP and
anthropometry, while taking major maternal nutrition-related
cofactors potentially affecting fetal growth and body composition
into account. We hypothesize that imbalanced intake of LCPUFA
during pregnancy, resultant of excessive n-6 intake and/or
insufﬁcient n-3 intake, increases adiposity of the fetus.
METHODS
This study is part of a broader study on the inﬂuence of maternal nutrition
on body composition of offspring, conducted in the maternity and the
nutrition laboratory of a level III pediatric hospital. Ethical committee
approval and parental-informed consent were obtained.
The cross-sectional study design and baseline subject characteristics
have been previously reported.10 To summarize, a convenience sample of
mother and infant dyads was systematically recruited, with the following
criteria for inclusion: proper medical surveillance of pregnancy ending with
a singleton neonate and full-term (⩾37 and ⩽ 41 weeks of gestation),
appropriate-for-gestational age (birth weight43rd ando97th percentiles
for gestational age and sex)19 neonates considered healthy. Some major
factors inﬂuencing maternal and fetal LCPUFA proﬁle in term pregnancies,
such as being small-for-gestational-age, grand multiparity (⩾5 pregnan-
cies) and multiple pregnancies were controlled in the study design by
exclusion.20 In addition, the recruitment excluded neonates whose
mothers had adverse conditions potentially affecting fetal nutrition and
growth, such as type 2 diabetes mellitus, abnormal oral glucose tolerance
test, inborn errors of metabolism, severe renal and cardiovascular disease,
diastolic blood pressure during pregnancy490mmHg or any reported
consumption of alcohol, tobacco or illicit drugs.21
Maternal diet was assessed by a semiquantitative 86-item food-
frequency questionnaire (FFQ) validated for Portuguese pregnant
women.22 There were nine response options that ranged from ‘never/
less than one per month’ to ‘six or more portions per day’. Women
answered this questionnaire once, in the immediate postpartum period, to
recall their usual dietary intake during the whole pregnancy. To estimate
food consumption, the reported frequency for each food item was
multiplied by their predetermined average portion pattern in grams. Food
Processor Plus 6.0 (ESHA Research, Salem, OR, USA) was used to convert
the consumption of food items into nutrients, based on thes United States
Department of Agriculture food composition data, and was complemented
with nutrient composition from the Portuguese Table of Food Composi-
tion.23 Mothers were speciﬁcally questioned on the intake of LCPUFA
supplements, including ﬁsh oil.
Daily intakes of eicosapentaenoic acid, DHA and arachidonic acid (expressed
in mg) and intakes of n-6:n-3 LCPUFA ratio were included for analysis.
Neonatal anthropometric measurements were performed within the ﬁrst
72 h after birth. Direct measurements were taken for weight, length and
midarm circumference using the recommended procedures.24 Indices
derived from weight and length were calculated to estimate body
adiposity: weight/length index as weight (g)/length (cm), BMI as weight
(kg)/squared length (m) and ponderal index as weight (g)/cubed length
(cm).24 WHO Anthro (version 3.2.2, 2011; www.who.int/childgrowth/
software/en/) was used for calculation and analyses of age- and sex-
speciﬁc Z-scores of anthropometric data.25
The body composition of the neonates was measured using ADP (Pea
Pod; Life Measurement Instruments, Concord, CA, USA), a two-compartment
model measuring body mass (kg) with precision of 0.1 g of fat mass and fat-
free mass. The percentage of body fat was calculated from body density
assuming the density of fat to be 0.9007, and age- and sex-speciﬁc densities
of fat-free mass were computed based on the data of Fomon.17
Results are expressed as mean (standard deviation) or median (minimum,
maximum), as appropriate. An analysis was conducted to identify
interactions between sex and LCPUFA intake regarding the percentage of
fat mass (%FM) as main outcome. Linear multiple regression analyses were
performed including variables identiﬁed by univariate analysis (Po0.15).
Models for either neonatal anthropometry or ADP measurements con-
sidered gestational age, maternal intakes of eicosapentaenoic acid, DHA,
arachidonic acid and n-6:n-3 LCPUFA ratio as independent variables. In these
models, energy and macronutrient intake, prepregnancy BMI (as a conti-
nuous variable and categorized for the threshold 25 kgm−2) and GWG (as a
continuous variable and categorized for the threshold 10 kg) were also
considered as independent variables according to previously described
criteria.10 Daily maternal DHA intake was used as a continuous variable and
categorized for the threshold of recommended ⩾ 200mg daily intake.3 The
level of signiﬁcance was α=0.05. Data were analyzed using the Statistical
Package for the Social Sciences 19.0 for Windows (SPSS, Chicago, IL, USA).
RESULTS
Neonates had a mean birth weight of 3.360 (0.359) kg and 55
(55%) of them were female. Median postnatal age of assessment
was 50 (min. 23; max. 75) hours. The mean age of the mothers was
29.7 (6.1) years. Male offspring were found to have signiﬁcantly
greater weight, length and fat-free mass compared with females,
and a signiﬁcant positive correlation was found between anthro-
pometric measurements and ADP measurements. These and
additional results are published elsewhere.10
The LCPUFA intakes during pregnancy, considered as contin-
uous variables, are described in Table 1. It was found that 39% of
the mothers consumed less than the recommended daily intake
of 200mg per day.3 No mother received supplementation of
LCPUFA, including ﬁsh oil.
Upon analysis, several interactions were identiﬁed between
sex and LCPUFA intake in regard to %FM, particularly more
pronounced (P= 0.015) between sex and n-6:n-3 LCPUFA ratio
intake. This distinct effect of the estimated n-6:n-3 LCPUFA ratio
intake on the %FM of male and female offspring highlighted the
need to stratify the analysis by sex:
- In male offspring, the ponderal index was positively associated
with maternal DHA intake (β-estimate = 0.165; 95% conﬁdence
interval (CI): 0.031, 0.299; P= 0.017), prepregnancy BMI (β-
estimate = 0.188; 95% CI: 0.050, 0.326; P= 0.009) and GWG (β-
estimate = 0.150; 95% CI: 0.016, 0.285; P= 0.029). This indicates
that when maternal DHA intake was sufﬁcient (⩾200 mg), the
male offspring ponderal index was an average 0.165 g cm− 3
higher after adjusting for BMI and GWG (Table 2).
- In female offspring, the n-6:n-3 LCPUFA ratio intake was
positively associated with fat mass (β-estimate = 0.021; 95% CI:
0.002, 0.041; P= 0.034) and %FM (β-estimate = 0.636; 95% CI:
0.125, 1.147; P= 0.016). This indicates that for each unit increase
on the estimated maternal n-6:n-3 LCPUFA ratio intake, the
female offspring fat mass was an average of 21 g heavier and
the %FM was an average of 0.64% higher (Table 3).
DISCUSSION
This cross-sectional study conducted in an Atlantic European
country, was designed to analyze the inﬂuence of nutrition during
pregnancy on the body composition at birth of full-term
appropriate-for-gestational age neonates born to mothers without
known potential factors affecting the intrauterine growth.10 The
presented subanalysis focuses on the adjusted effect of maternal
LCPUFA intake on the body composition of those neonates.
This study has two strong points that should be emphasized:
the assessment of adiposity at birth by measuring the %FM using
Table 1. Estimated daily LCPUFA intakes during pregnancy
Daily intakes Median Min; max
AA (mg) 168.5 61; 536
EPA (mg) 114.5 2; 502
DHA (mg) 266.0 10; 1210
n-6:n-3 LCPUFA ratio 7.0 3.9, 19.0
Abbreviations: AA, arachidonic acid; DHA, docosahexaenoic acid; EPA,
eicosapentaenoic acid; LCPUFA, long-chain polyunsaturated fatty acids.
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ADP, as a reliable and precise method with recent increasing
use;16,17,26,27 and the assessment of the effect of maternal LCPUFA
intake on the body composition at birth adjusted for three major
maternal nutrition cofactors (prepregnancy BMI, energy and
macronutrient intakes during pregnancy, and GWG).
Some limitations have to be acknowledged. A systematically
recruited convenience sample was studied. Despite its conve-
nience size, most of the associations obtained in this sample are
strong, as evidenced by the statistical signiﬁcance and narrow
conﬁdence intervals. To avert the potential effect of non-assessed
placental pathology on outcome measurements, neonates born to
mothers with adverse conditions known to affect fetal nutrition
and growth were excluded, and only assumed healthy full-term
appropriate-for-gestational age neonates were included. Owing to
safety concerns, it was not feasible to perform the assessments in
the ﬁrst hours after birth; thus, the physiological water loss
occurring in the ﬁrst days after birth is an uncontrollable bias.
A semiquantitative validated FFQ was administered in the
immediate postpartum period to assess maternal diet during
pregnancy. In spite of the potential recollection bias inherent to
the FFQ, the quality of the n-3 fatty acids estimates derived from
the FFQ has been judged as acceptable according to the European
micronutrient Recommendations Aligned scoring system.28 In fact,
in several observational studies assessing the effect of maternal
LCPUFA intake on fetal health, the FFQ has been administered
either during pregnancy or following delivery. 5,29–31
The neonatal body composition assessed within the ﬁrst 72 h
after birth allowed the best feasible estimate of the intrauterine
nutritional status,32 while minimizing the effect of postnatal
factors such as the feeding regimen. Most of studies analyzing
the effect of maternal LCPUFA intake have not restricted the
intervention to the prenatal period but continued the exposure
during lactation, thus making it difﬁcult to interpret the potential
independent effects of variations in LCPUFA supply on intrauter-
ine developing fat depots.6
Only few studies have adjusted the analysis for major cofactors
inﬂuencing fetal body composition at term birth, such as maternal
BMI,33–37 total energy intake during pregnancy35 and GWG.31 Data
previously reported on the same sample10 demonstrated positive
adjusted associations between both prepregnancy BMI and
energy intake from carbohydrate and offspring body size, positive
association between prepregnancy overweight and adiposity in
male offspring, and positive association between GWG and body
size in female offspring. In this study, using the same reliable
method for measuring %FM, a signiﬁcant interaction was
identiﬁed between sex and estimated n-6:n-3 LCPUFA ratio intake.
Moreover, it has been reported that females have signiﬁcantly
greater fat mass and %FM at birth than males.18 Therefore, further
analysis was done to stratify by sex.
Adjustment for maternal nutritional factors and gestational age,
with the use of both ADP and anthropometry, revealed clinically
signiﬁcant positive associations in regard to the effect of maternal
LCPUFA intake on offspring body composition. Among male
offspring, with mean ponderal index of 2.8 g cm− 3,10 the ponderal
index was on average 0.165 g cm− 3 higher (circa 5.9%) when
maternal DHA intake reached sufﬁcient requirements.3 Among
female offspring, with mean fat mass of 370 g and %FM of
11.6%,10 the fat mass increased 21 g (circa 5.7%) and adiposity
(%FM) increased 0.64% (circa 5.5%) for each one unit increase in
maternal n-6:n-3 LCPUFA ratio intake (ranging from 3.9 to 19.0).
Although weight:length ratios at birth, such as BMI and ponderal
index, may give a more complete insight into size at birth, they do
not distinguish between the major components of body mass and
therefore provide poor assessment of adiposity.6 Of note, increase
in fat-free mass such as bone cannot be accounted for using
BMI and/or ponderal index. DHA, in sufﬁcient intake, seems to
modulate the differentiation of mesenchymal bone marrow cells
toward osteoblastogenesis rather than adipocytes.38 It is possible
that positive associations seen between adequate DHA intake and
BMI and/or ponderal index could be related to changes in bone
mass rather than increased adiposity. It has been suggested that
ponderal index may correlate better with lean mass rather than
adiposity.16 Correspondingly, Much et al.14 found neonatal n-3
LCPUFA status to be negatively associated with fat mass at birth.
The positive association found between estimated maternal n-6:
n-3 LCPUFA ratio intake and adiposity in female offspring may be
explained by adipogenic effect resulting from proportionally
increased n-6 LCPUFA intake and/or reduced n-3 LCPUFA
intake.1,4,6,11 This positive association is not consistent with the
ﬁndings of either Hauner et al.13 or Much et al.,14 who did not ﬁnd
signiﬁcant effect of the variation in n-6:n-3 LCPUFA ratio intake
during pregnancy and lactation on offspring fat mass during the
ﬁrst year of life. Hauner et al.13 estimated total body fat using
skinfold measurements and Much et al.14 evaluated the adiposity
using both skinfolds and regional fat estimated by ultrasound
measurements of abdominal subcutaneous fat and preperitoneal
fat thickness. Notwithstanding, skinfolds have limitations in
predicting body fat at least in the neonatal period.15 Hauner
et al.13 did not ﬁnd evidence of an interaction between maternal
n-6:n-3 ratio intake and sex, considering fat mass as the outcome.
Nevertheless, sexual dimorphism in offspring response to
maternal n-3 LCPUFA intake has been reported at least in relation
to brain development.39 It has been suggested that human
females need greater amounts of adipose tissue, stored in early
life, in order to provide sufﬁcient amounts of DHA to support
growth of long brains in their developing fetus.39
To summarize, in coherence with the reported adipogenic effect
of n-6 family and anti-adipogenic effect of n-3 family,1,4,6,11 the
adiposity of female offspring (elicited by %FM and fat mass) was
found to be positively associated with a maternal LCPUFA ratio
intake favoring n-6 over n-3 LCPUFA. Consistent with reports of
increased birth size associated with maternal n-3 LCPUFA
intake,2,4,5,7 the ponderal index of male offspring was positively
associated with maternal DHA intake.
Table 2. Association between PI at birth in male offspring and
estimated DHA intake during pregnancy, adjusted to prepregnancy
BMI and GWG
Maternal variables β Estimate (95% CI) P-value
DHA intake 0.165 (0.031, 0.299) 0.017
Prepregnancy BMI
(threshold 25 kgm− 2)
0.188 (0.050, 0.326) 0.009
GWG (threshold 10 kg) 0.150 (0.016, 0.285) 0.029
Abbreviations: CI, conﬁdence interval; PI, ponderal index; GWG, gestational
weight gain. Variables considered for the multivariable model: DHA intake,
prepregnancy BMI and GWG (as categorical variables).
Table 3. Association between %FM and FM at birth in female
offspring and estimated n-6:n-3 LCPUFA ratio intake during pregnancy
Neonatal measurements n-6:n-3 LCPUFA ratio P-value
β estimate (95% CI)
%FMa 0.636 (0.125, 1.147) 0.016
FMb 0.021 (0.002, 0.041) 0.034
Abbreviations: CI, conﬁdence interval; %FM, percentage of fat mass, FM, fat
mass, LCPUFA, long-chain polyunsaturated fatty acids. Variables considered
for the multivariable model. aPrepregnancy BMI (as categorical variable)
and n-6:n-3LCPUFA ratio intake. bn-6:n-3LCPUFA ratio intake as the only
signiﬁcant variable identiﬁed by univariate analysis.
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In conclusion, the assessment of body composition of healthy
full-term offspring at birth using both anthropometry and ADP
revealed signiﬁcant positive associations between estimated
maternal DHA intake and body size (reﬂected by ponderal index)
in male offspring, and between estimated maternal n-6:n-3
LCPUFA intake and adiposity (elicited by %FM and fat mass) in
female offspring, suggesting that maternal LCPUFA intake strongly
inﬂuences fetal body composition.
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